53S1.F · The Supreme Cannabis Company, Inc

-

Please sign in to comment on 53S1.F

1 Comment

Admin

4 years, 1 month ago

The Supreme Cannabis Company, Inc is currently in a long term uptrend where the price is trading 35.1% above its 200 day moving average.

From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.

The Supreme Cannabis Company, Inc's total revenue rose by 102.1% to $18M since the same quarter in the previous year.

Its net income has increased by 54.3% to $-8M since the same quarter in the previous year.

Finally, its free cash flow grew by 99.0% to $-352K since the same quarter in the previous year.

Based on the above factors, The Supreme Cannabis Company, Inc gets an overall score of 5/5.

ISIN	None
Exchange	F
CurrencyCode	EUR
Sector
Industry

Market Cap	169M
PE Ratio	None
Target Price	None
Beta	2.19
Dividend Yield	None

ABOUT

The Supreme Cannabis Company, Inc

The Supreme Cannabis Company, Inc. engages in the production of medical cannabis products in Canada. The company was formerly known as Supreme Pharmaceuticals Inc. and changed its name to The Supreme Cannabis Company, Inc. in December 2017. The Supreme Cannabis Company, Inc. was incorporated in 1979 and is headquartered in Toronto, Canada. As of June 22, 2021, The Supreme Cannabis Company, Inc. operates as a subsidiary of Canopy Growth Corporation.

53S1.F · The Supreme Cannabis Company, Inc

-

The Supreme Cannabis Company, Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest The Supreme Cannabis Company, Inc using a moving average strategy